Camila Batista da Silva

Dr. Camila Batista da Silva

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BMBruno Vilela Muniz
Bruno Vilela Muniz
DBDiego Baratelli
Diego Baratelli
SCStephany Di Carla
Stephany Di Carla
LSLuciano Serpe
Luciano Serpe
CSCamila Batista da Silva
Camila Batista da Silva
Michelle Franz-MontanMichelle Franz-Montan
Michelle Franz-Montan
This study reports the development of nanostructured hydrogels for the sustained release of the eutectic mixture of lidocaine and prilocaine (both at 2.5%) for intraoral topical use. The local anesthetics, free or encapsulated in poly(ε-caprolactone) nanocapsules, were incorporated into CARBOPOL hydrogel. The nanoparticle suspensions were characterized in vitro in terms of particle size, polydispersity, and surface charge, using dynamic light scattering measurements. The nanoparticle concentrations were determined by nanoparticle tracking analysis. Evaluation was made of physicochemical stability, structural features, encapsulation efficiency, and in vitro release kinetics. The CARBOPOL hydrogels were submitted to rheological, accelerated stability, and in vitro release tests, as well as determination of mechanical and mucoadhesive properties, in vitro cytotoxicity towards FGH and HaCaT cells, and in vitro permeation across buccal and palatal mucosa. Anesthetic efficacy was evaluated using Wistar rats. Nanocapsules were successfully developed that presented desirable physicochemical properties and a sustained release profile. The hydrogel formulations were stable for up to 6 months under critical conditions and exhibited non-Newtonian pseudoplastic flows, satisfactory mucoadhesive strength, non-cytotoxicity, and slow permeation across oral mucosa. In vivo assays revealed higher anesthetic efficacy in tail-flick tests, compared to a commercially available product. In conclusion, the proposed hydrogel has potential for provision of effective and longer-lasting superficial anesthesia at oral mucosa during medical and dental procedures. These results open perspectives for future clinical trials.

1 March 2010 in Journal of Endodontics
Verified
Journal Article
Closed access
CSCamila Batista da Silva
Camila Batista da Silva
LBLuciana Aranha Berto
Luciana Aranha Berto
MVMaria Cristina Volpato
Maria Cristina Volpato
JRJuliana Cama Ramacciato
Juliana Cama Ramacciato
RMRogério Heládio Lopes Motta
Rogério Heládio Lopes Motta
FGFrancisco Carlos Groppo
Francisco Carlos Groppo

22 December 2016 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
SFSára Costa Ferreira-Rodrigues
Sára Costa Ferreira-Rodrigues
CRCássio Milhomens Rodrigues
Cássio Milhomens Rodrigues
MSMarcio Galdino Dos Santos
Marcio Galdino Dos Santos
JGJean Antonio Abraham Gautuz
Jean Antonio Abraham Gautuz
MSMagali Glauzer Silva
Magali Glauzer Silva
YOYoko Oshima-Franco
Yoko Oshima-Franco
Anti-Inflammatory and Antibothropic Properties of Jatropha Elliptica, a Plant from Brazilian Cerrado Biome

5 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CSCamila Batista da Silva
Camila Batista da Silva
Michelle Franz-MontanMichelle Franz-Montan
Michelle Franz-Montan
CLCíntia Elisabeth Gomez Limia
Cíntia Elisabeth Gomez Limia
Lígia Nunes de Morais RibeiroLígia Nunes de Morais Ribeiro
Lígia Nunes de Morais Ribeiro
MBMário Antônio Braga
Mário Antônio Braga
Eneida De PaulaEneida De Paula
Eneida De Paula
Ropivacaine is a local anesthetic with similar potency but lower systemic toxicity than bupivacaine, the most commonly used spinal anesthetic. The present study concerns the development of a combined drug delivery system for ropivacaine, comprised of two types of liposomes: donor multivesicular vesicles containing 250 mM (NH4)2SO4 plus the anesthetic, and acceptor large unilamellar vesicles with internal pH of 5.5. Both kinds of liposomes were composed of hydrogenated soy-phosphatidylcholine:cholesterol (2:1 mol%) and were prepared at pH 7.4. Dynamic light scattering, transmission electron microscopy and electron paramagnetic resonance techniques were used to characterize the average particle size, polydispersity, zeta potential, morphology and fluidity of the liposomes. In vitro dialysis experiments showed that the combined liposomal system provided significantly longer (72 h) release of ropivacaine, compared to conventional liposomes (~45 h), or plain ropivacaine (~4 h) (p <0.05). The pre-formulations tested were significantly less toxic to 3T3 cells, with toxicity increasing in the order: combined system < ropivacaine in donor or acceptor liposomes < ropivacaine in conventional liposomes < plain ropivacaine. The combined formulation, containing 2% ropivacaine, increased the anesthesia duration up to 9 h after subcutaneous infiltration in mice. In conclusion, a promising drug delivery system for ropivacaine was described, which can be loaded with large amounts of the anesthetic (2%), with reduced in vitro cytotoxicity and extended anesthesia time.

1 May 2019 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
LSLuciano Serpe
Luciano Serpe
BMBruno Vilela Muniz
Bruno Vilela Muniz
CSCleiton Pita dos Santos
Cleiton Pita dos Santos
CSCamila Batista da Silva
Camila Batista da Silva
MVMaria Cristina Volpato
Maria Cristina Volpato
Michelle Franz-MontanMichelle Franz-Montan
Michelle Franz-Montan

27 January 2016 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
PDF file
CSCamila Batista da Silva
Camila Batista da Silva
FGFrancisco Carlos Groppo
Francisco Carlos Groppo
CSCleiton Pita dos Santos
Cleiton Pita dos Santos
LSLuciano Serpe
Luciano Serpe
Michelle Franz-MontanMichelle Franz-Montan
Michelle Franz-Montan
MVMaria Cristina Volpato
Maria Cristina Volpato